Insider Transactions in Q4 2021 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,887
-0.9%
|
$6,887
$1.02 P/Share
|
|
Dec 31
2021
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,484
-0.9%
|
$1,484
$1.02 P/Share
|
|
Dec 31
2021
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,250
-0.81%
|
$1,250
$1.02 P/Share
|
|
Dec 31
2021
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
206
-0.24%
|
$206
$1.02 P/Share
|
|
Nov 30
2021
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,705
+0.61%
|
$0
$0.88 P/Share
|
|
Nov 30
2021
|
Patrick G Lepore Director |
BUY
Open market or private purchase
|
Direct |
12,500
+16.67%
|
$12,500
$1.02 P/Share
|
|
Nov 30
2021
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,187
+4.56%
|
$0
$0.88 P/Share
|